lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p
Turkish Journal of Gastroenterology · 2024
DOI: 10.5152/tjg.2024.24150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2024. Verfasst von Yimei Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Endoscopy, Third Affiliated Hospital of Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aims: Identifying novel therapeutic targets for hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) has become a key goal in liver cancer research. Even though long non-coding RNAs (lncRNAs) do not code proteins, they could regulate the expression of functional genes and thus mediate disease development. The aim of this study was to estimate the role of lncRNA POLR2J4 (POLR2J4) in the progression of hepatitis B virus-related hepatocellular carcinoma (HBV–HCC) to pinpoint a potential biomarker. Materials and Methods: This study included 109 patients diagnosed with HBV-positive HCC, from whom tissue samples were collected. The expression level of POLR2J4 was evaluated by qPCR. The significance of POLR2J4 in HBV–HCC development and prognosis was estimated by Chi-square, Kaplan-Meier, and Cox analysis. In vitro, POLR2J4 was regulated in HBV–HCC cells, and its effect on cell growth and metastasis was assessed by CCK8 and Transwell assay. The interaction between POLR2J4 and miR-214-3p was evaluated through the luciferase reporter and RNA immunoprecipitation assays.
Results
In tumor tissues of HBV–HCC patients, there was an observed increase in the expression of POLR2J4. The increase was closely related with patients’ presence of cirrhosis and vascular invasion, higher AFP, and advanced Edmondson grade and TNM stage. An upregulation of POLR2J4 predicted a poor prognosis for HBV–HCC patients and served as an independent indicator. In HBV-related HCC cells, silencing POLR2J4 suppressed cell proliferation, migration, and invasion. Furthermore, POLR2J4 negatively regulated miR-214-3p reversing the inhibition of cellular processes.
Conclusion
POLR2J4 acted as a prognostic biomarker and a tumor promoter of HBV–HCC by modulating miR-214-3p. Cite this article as: Ji Y, Chen X, Liu X, Huang J, Liu P. LncRNA POLR2J4 plays a biomarker role in hepatitis B virus-related hepatocellular carcinoma through regulating miR-214-3p. Turk J Gastroenterol. 2024;35(10):787-794.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Endoscopy, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
- Department of Interventional, The First Hospital of China Medical University, Shenyang, China.
- Department of Infectious Diseases, The First People's Hospital of Neijiang, Neijiang, China.
- Department of General Surgery (Thyroid Gland/Blood Vessel), The First People's Hospital of Neijiang, Neijiang, China.
- Department of Ultrasound Interventional, Third Affiliated Hospital of Naval Medical University, Shanghai, China.
Zitieren
APA
Ji, Y., Chen, X., Liu, X., Huang, J., & Liu, P. (2024). lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2024.24150
Vancouver
Ji Y, Chen X, Liu X, Huang J, Liu P. lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p. Turkish Journal of Gastroenterology. 2024. doi:10.5152/tjg.2024.24150
BibTeX
@article{Ji2024,
author = {Ji, Yimei and Chen, Xiaowei and Liu, Xin and Huang, Jianyuan and Liu, Pei},
title = {lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p},
journal = {Turkish Journal of Gastroenterology},
year = {2024},
doi = {10.5152/tjg.2024.24150}
}
EUVIMED